Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04057157 · ClinicalTrials.gov registry record
Post-market Assessment of Biodesign Dural Repair Grafts
A clinical trial, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- 128
- Enrollment target
NCT04057157 is a clinical trial that has completed, run by Cook Research Incorporated. The registered enrollment target is 128 participants.
The verdict
NCT04057157 has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- 128 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to gather post-market clinical evidence on the use of the Biodesign® Dural and Duraplasty Grafts when used as a dura substitute of the dura mater.
Interventions
- DEVICE Biodesign Dural or Duraplasty Repair Grafts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2019-09-03 |
| Est. Completion | 2022-09-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04057157
The ClinicalTrials.gov registry entry for NCT04057157 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biodesign Dural or Duraplasty Repair Grafts is the first listed.
NCT04057157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04057157 about?
NCT04057157 is a clinical study titled "Post-market Assessment of Biodesign Dural Repair Grafts". The purpose of this clinical study is to gather post-market clinical evidence on the use of the Biodesign® Dural and Duraplasty Grafts when used as a dura substitute of the dura mater.
What is the current status of trial NCT04057157?
This trial is currently completed. The enrollment target is 128 participants. The study started on 2019-09-03. Estimated completion is 2022-09-15.
What interventions are being tested in trial NCT04057157?
The interventions under investigation include: Biodesign Dural or Duraplasty Repair Grafts (DEVICE).
Who is sponsoring clinical trial NCT04057157?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.